Correction to “Functional near‐infrared spectroscopy as a biomarker of TMS efficacy in treatment‐resistant depression”

Ähnliche Einträge

• Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
  von: Yasmin Esmaeilian, et al.
  Veröffentlicht: (2026)
• Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder
  von: Shugui Gao, et al.
  Veröffentlicht: (2025)
• Acute and long‐term effects of repeated ketamine infusions in treatment‐resistant depression and associated metabolite changes
  von: Hitoshi Sakurai, et al.
  Veröffentlicht: (2025)
• Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
  von: Beatrice Bravi, et al.
  Veröffentlicht: (2024)
• Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
  von: Alexander A. Yakovlev
  Veröffentlicht: (2024)